Trial reportJournal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine2026
Deresuscitation Informed by Ultrasound in Patients With Septic Shock Trial: A Pilot Randomized Controlled Study.
Trial report in Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectivesThe venous excess ultrasound (VExUS) can be used at the point-of-care to identify venous overload and end-organ congestion in an effort to individually tailor resuscitation and deresuscitation in patients with septic shock.
methodsWe conducted a pilot randomized controlled feasibility trial of VExUS-guided fluid management in adult patients with septic shock. Participants were randomized to VExUS-guided fluid management or usual care. Daily ultrasounds were performed on all participants; in the VExUS-guided study arm, the clinical care team was informed of the VExUS results and given a fluid management recommendation (the intervention).
resultsWe enrolled 19 participants; 12 (63%) were randomized to the VExUS arm. The intervention period fluid balance was -65 mL (interquartile range [IQR] -1733 to 2016) in the VExUS arm compared to 2608 mL (IQR -435 to 4460) in the usual care arm (p = .21). The secondary outcomes of acute kidney injury, respiratory failure, hospital, and 30-day mortality did not differ significantly between the 2 arms; although the rates were lower in the VExUS arm.
conclusionsWe demonstrate that VExUS-guided fluid management in patients with septic shock is feasible, was not associated with an increased risk of adverse events, and may reduce the volume of fluids administered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.